| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | SLIT2 RELN TINAG VWF TNC MATN2 CRELD2 NID1 LAMC2 TECTA ZP4 MUC2 SSPOP MUC5AC TNXB MUC6 | 1.13e-18 | 188 | 66 | 16 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | SLIT2 RELN TINAG VWF TNC MATN2 CRELD2 NID1 LAMC2 TECTA ZP4 MUC2 SSPOP MUC5AC TNXB MUC6 OTOG | 3.03e-09 | 891 | 66 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | calcium ion binding | SNED1 SLIT2 NELL2 STAB2 MEGF6 MATN2 NOTCH2NLA LRP4 CRELD2 NID1 PRKCSH NOTCH2NLC EGFEM1P NOTCH4 CRB1 | 1.61e-08 | 749 | 66 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | integrin binding | 1.77e-06 | 175 | 66 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | Notch binding | 1.80e-06 | 27 | 66 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.80e-06 | 27 | 66 | 4 | GO:0005044 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity involved in amyloid precursor protein catabolic process | 6.43e-05 | 4 | 66 | 2 | GO:1902945 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.80e-04 | 85 | 66 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.56e-04 | 268 | 66 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 2.97e-04 | 8 | 66 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | heparin binding | 4.34e-04 | 192 | 66 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 6.41e-04 | 51 | 66 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 6.71e-04 | 120 | 66 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | Roundabout binding | 6.95e-04 | 12 | 66 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 6.95e-04 | 12 | 66 | 2 | GO:0017154 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.37e-03 | 654 | 66 | 8 | GO:0008233 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.82e-03 | 73 | 66 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.97e-03 | 20 | 66 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | collagen binding | 2.45e-03 | 81 | 66 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.94e-03 | 430 | 66 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 3.55e-03 | 599 | 66 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 4.29e-03 | 323 | 66 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 4.34e-03 | 200 | 66 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | laminin binding | 5.64e-03 | 34 | 66 | 2 | GO:0043236 | |
| GeneOntologyBiologicalProcess | neuron projection development | PLXNA3 SLIT2 NELL2 RELN IGFALS TNC TNN MATN2 LRP4 LAMC2 PRKCSH TECTA ADAM10 PRAG1 TNR GDI1 TNXB PLXNA2 OTOG | 1.14e-08 | 1285 | 66 | 19 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | PLXNA3 SLIT2 NELL2 RELN IGFALS TNC TNN MATN2 LRP4 LAMC2 PRKCSH TECTA ADAM10 PRAG1 TNR GDI1 TNXB PLXNA2 CRB1 OTOG | 1.58e-08 | 1463 | 66 | 20 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PLXNA3 SLIT2 NELL2 RELN IGFALS TNN MATN2 LRP4 LAMC2 TECTA ADAM10 TNR GDI1 PLXNA2 | 8.12e-08 | 748 | 66 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | axon development | PLXNA3 SLIT2 NELL2 RELN IGFALS TNC TNN MATN2 LRP4 LAMC2 TNR GDI1 PLXNA2 | 1.02e-07 | 642 | 66 | 13 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell morphogenesis | PLXNA3 SLIT2 NELL2 RELN IGFALS TNN MATN2 LRP4 LAMC2 TECTA ADAM10 PRAG1 TNR GDI1 PLXNA2 NOTCH4 CRB1 | 1.39e-07 | 1194 | 66 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | axonogenesis | PLXNA3 SLIT2 NELL2 RELN IGFALS TNN MATN2 LRP4 LAMC2 TNR GDI1 PLXNA2 | 2.07e-07 | 566 | 66 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 1.14e-06 | 169 | 66 | 7 | GO:0010977 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | PLXNA3 SLIT2 NELL2 RELN IGFALS TNN MATN2 LRP4 LAMC2 ADAM10 TNR GDI1 PLXNA2 | 1.28e-06 | 802 | 66 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 1.62e-06 | 62 | 66 | 5 | GO:0050771 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PLXNA3 SLIT2 NELL2 RELN IGFALS TNN MATN2 LRP4 LAMC2 ADAM10 TNR GDI1 PLXNA2 | 1.62e-06 | 819 | 66 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PLXNA3 SLIT2 NELL2 RELN IGFALS TNN MATN2 LRP4 LAMC2 ADAM10 TNR GDI1 PLXNA2 | 1.78e-06 | 826 | 66 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | axon guidance | 3.46e-06 | 285 | 66 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | PLXNA3 SLIT2 RELN TNN LRP4 PRKCSH ADAM10 PRAG1 TNR GDI1 PLXNA2 | 3.50e-06 | 612 | 66 | 11 | GO:0010975 |
| GeneOntologyBiologicalProcess | neuron projection guidance | 3.55e-06 | 286 | 66 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | PLXNA3 ADAM19 TNC TNN NID1 PLG ZP4 ADAM10 TNR TNXB PLXNA2 MEGF10 NOTCH4 | 6.27e-06 | 927 | 66 | 13 | GO:0030155 |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 9.48e-06 | 233 | 66 | 7 | GO:0031345 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 3.23e-05 | 114 | 66 | 5 | GO:0008593 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 3.44e-05 | 192 | 66 | 6 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 3.99e-05 | 21 | 66 | 3 | GO:2000047 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 4.77e-05 | 410 | 66 | 8 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | PLXNA3 SLIT2 RELN TNN LRP4 PRKCSH ADAM10 PRAG1 TNR GDI1 PLXNA2 | 7.06e-05 | 846 | 66 | 11 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | PLXNA3 SLIT2 RELN TNN LRP4 PRKCSH ADAM10 PRAG1 TNR GDI1 PLXNA2 | 8.43e-05 | 863 | 66 | 11 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | PLXNA3 SLIT2 RELN TNN LRP4 PLG ADAM10 PRAG1 TNR GDI1 PLXNA2 NOTCH4 | 1.56e-04 | 1090 | 66 | 12 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of cell motility | PLXNA3 SLIT2 RELN TNC TNN LAMC2 PLG ADAM10 PRAG1 MUC2 TNR TNXB PLXNA2 | 1.78e-04 | 1280 | 66 | 13 | GO:2000145 |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 1.92e-04 | 375 | 66 | 7 | GO:0007162 | |
| GeneOntologyBiologicalProcess | cerebral cortex tangential migration | 2.10e-04 | 7 | 66 | 2 | GO:0021800 | |
| GeneOntologyBiologicalProcess | recognition of apoptotic cell | 2.10e-04 | 7 | 66 | 2 | GO:0043654 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 2.24e-04 | 270 | 66 | 6 | GO:0007160 | |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 2.32e-04 | 173 | 66 | 5 | GO:0050768 | |
| GeneOntologyBiologicalProcess | negative regulation of axon extension | 2.44e-04 | 38 | 66 | 3 | GO:0030517 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | PLXNA3 SLIT2 RELN TNC TNN LAMC2 PLG ADAM10 PRAG1 MUC2 TNR TNXB PLXNA2 | 2.54e-04 | 1327 | 66 | 13 | GO:0040012 |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 3.08e-04 | 184 | 66 | 5 | GO:0051961 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 3.46e-04 | 104 | 66 | 4 | GO:0030516 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 3.86e-04 | 299 | 66 | 6 | GO:0060560 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | PLXNA3 SLIT2 RELN TNC TNN LAMC2 PLG ADAM10 MUC2 TNR TNXB PLXNA2 | 4.10e-04 | 1211 | 66 | 12 | GO:0030334 |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 4.46e-04 | 10 | 66 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | growth | PLXNA3 SLIT2 RERG NELL2 TNC TNN LRP4 PLG ADAM10 TNR GDI1 RAI1 | 4.89e-04 | 1235 | 66 | 12 | GO:0040007 |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 4.90e-04 | 114 | 66 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 5.27e-04 | 207 | 66 | 5 | GO:1990138 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 5.51e-04 | 50 | 66 | 3 | GO:0044331 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 5.63e-04 | 210 | 66 | 5 | GO:0007219 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SLIT2 ADAM19 SCARF2 PLG ZP4 TNR TNXB MEGF10 NOTCH4 CRB1 PEAR1 | 5.71e-04 | 1077 | 66 | 11 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative chemotaxis | 5.84e-04 | 51 | 66 | 3 | GO:0050919 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 6.33e-04 | 122 | 66 | 4 | GO:0061387 | |
| GeneOntologyBiologicalProcess | telencephalon development | 6.71e-04 | 332 | 66 | 6 | GO:0021537 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental growth | 7.14e-04 | 126 | 66 | 4 | GO:0048640 | |
| GeneOntologyBiologicalProcess | pallium development | 7.24e-04 | 222 | 66 | 5 | GO:0021543 | |
| GeneOntologyBiologicalProcess | regulation of growth | 7.89e-04 | 777 | 66 | 9 | GO:0040008 | |
| GeneOntologyBiologicalProcess | cell growth | 8.30e-04 | 625 | 66 | 8 | GO:0016049 | |
| GeneOntologyBiologicalProcess | axon extension | 9.24e-04 | 135 | 66 | 4 | GO:0048675 | |
| GeneOntologyBiologicalProcess | cerebral cortex development | 1.27e-03 | 147 | 66 | 4 | GO:0021987 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.27e-03 | 515 | 66 | 7 | GO:0050767 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.29e-03 | 377 | 66 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.31e-03 | 378 | 66 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | 1.32e-03 | 519 | 66 | 7 | GO:0001558 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.33e-03 | 379 | 66 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | PLXNA3 SLIT2 PRAMEF5 TNN LRP4 PLG TNR GDI1 PRAMEF6 NOTCH4 RAI1 | 1.58e-03 | 1220 | 66 | 11 | GO:0051093 |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 1.59e-03 | 72 | 66 | 3 | GO:0022029 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 1.79e-03 | 75 | 66 | 3 | GO:0021885 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 1.81e-03 | 875 | 66 | 9 | GO:0045596 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | 2.12e-03 | 283 | 66 | 5 | GO:0045926 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 2.23e-03 | 81 | 66 | 3 | GO:0031102 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 2.24e-03 | 22 | 66 | 2 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 2.24e-03 | 22 | 66 | 2 | GO:1902284 | |
| GeneOntologyBiologicalProcess | developmental growth | 2.37e-03 | 911 | 66 | 9 | GO:0048589 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | PLXNA3 SLIT2 RELN STAB2 PRAMEF5 PNPLA6 TNN PLG PLXNA2 PRAMEF6 NOTCH4 CRB1 | 2.38e-03 | 1483 | 66 | 12 | GO:0048646 |
| GeneOntologyCellularComponent | extracellular matrix | SNED1 SLIT2 RELN TINAG ADAM19 FCGBP VWF IGFALS MEGF6 TNC TNN MATN2 NID1 LAMC2 CRISP3 MUC5B PLG TECTA ZP4 ADAM10 MUC2 TNR SSPOP MUC5AC TNXB MUC6 PLXNA2 OTOG | 3.02e-25 | 656 | 65 | 28 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SNED1 SLIT2 RELN TINAG ADAM19 FCGBP VWF IGFALS MEGF6 TNC TNN MATN2 NID1 LAMC2 CRISP3 MUC5B PLG TECTA ZP4 ADAM10 MUC2 TNR SSPOP MUC5AC TNXB MUC6 PLXNA2 OTOG | 3.29e-25 | 658 | 65 | 28 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | SLIT2 RELN TINAG ADAM19 VWF MEGF6 TNC TNN MATN2 NID1 LAMC2 PLG ZP4 ADAM10 MUC2 TNR SSPOP TNXB PLXNA2 | 1.44e-15 | 530 | 65 | 19 | GO:0062023 |
| GeneOntologyCellularComponent | tenascin complex | 8.51e-11 | 4 | 65 | 4 | GO:0090733 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.49e-09 | 17 | 65 | 5 | GO:0098637 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.09e-06 | 59 | 65 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | mucus layer | 2.85e-05 | 3 | 65 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | basement membrane | 3.89e-05 | 122 | 65 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.71e-04 | 109 | 65 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 5.14e-04 | 11 | 65 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | cell surface | 5.79e-04 | 1111 | 65 | 11 | GO:0009986 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 7.26e-04 | 13 | 65 | 2 | GO:0002116 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 7.26e-04 | 13 | 65 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | phagocytic cup | 4.18e-03 | 31 | 65 | 2 | GO:0001891 | |
| Domain | EGF-like_dom | SNED1 SLIT2 NELL2 RELN ADAM19 STAB2 FCGBP MEGF6 ADAM23 SCARF2 TNC TNN MATN2 NOTCH2NLA LRP4 CRELD2 NID1 LAMC2 TECTA TNR NOTCH2NLC TNXB MEGF10 NOTCH4 CRB1 OTOG PEAR1 | 5.19e-34 | 249 | 65 | 27 | IPR000742 |
| Domain | EGF_3 | SNED1 SLIT2 NELL2 RELN ADAM19 STAB2 MEGF6 ADAM23 SCARF2 TNC TNN MATN2 NOTCH2NLA LRP4 CRELD2 NID1 TNR NOTCH2NLC SSPOP TNXB MEGF10 NOTCH4 CRB1 OTOG PEAR1 | 3.56e-31 | 235 | 65 | 25 | PS50026 |
| Domain | EGF | SNED1 SLIT2 NELL2 RELN STAB2 FCGBP MEGF6 ADAM23 SCARF2 TNC TNN MATN2 NOTCH2NLA LRP4 CRELD2 NID1 LAMC2 TECTA TNR NOTCH2NLC TNXB MEGF10 NOTCH4 CRB1 PEAR1 | 3.56e-31 | 235 | 65 | 25 | SM00181 |
| Domain | EGF_2 | SNED1 SLIT2 NELL2 RELN ADAM19 STAB2 MEGF6 ADAM23 SCARF2 TNC TNN MATN2 NOTCH2NLA LRP4 CRELD2 NID1 LAMC2 TNR NOTCH2NLC SSPOP TNXB MEGF10 NOTCH4 CRB1 PEAR1 | 7.86e-30 | 265 | 65 | 25 | PS01186 |
| Domain | EGF_1 | SNED1 SLIT2 NELL2 RELN ADAM19 STAB2 MEGF6 ADAM23 SCARF2 TNC TNN NOTCH2NLA LRP4 CRELD2 NID1 LAMC2 TNR NOTCH2NLC SSPOP TNXB MEGF10 NOTCH4 CRB1 PEAR1 | 1.42e-28 | 255 | 65 | 24 | PS00022 |
| Domain | EGF-like_CS | SNED1 SLIT2 NELL2 RELN ADAM19 STAB2 MEGF6 ADAM23 SCARF2 TNC TNN MATN2 NOTCH2NLA LRP4 CRELD2 NID1 LAMC2 TNR NOTCH2NLC TNXB MEGF10 NOTCH4 CRB1 PEAR1 | 2.52e-28 | 261 | 65 | 24 | IPR013032 |
| Domain | TIL | 9.17e-21 | 12 | 65 | 9 | PF01826 | |
| Domain | C8 | 9.17e-21 | 12 | 65 | 9 | PF08742 | |
| Domain | VWC_out | 1.14e-20 | 19 | 65 | 10 | SM00215 | |
| Domain | Unchr_dom_Cys-rich | 2.97e-20 | 13 | 65 | 9 | IPR014853 | |
| Domain | C8 | 2.97e-20 | 13 | 65 | 9 | SM00832 | |
| Domain | TIL_dom | 8.30e-20 | 14 | 65 | 9 | IPR002919 | |
| Domain | VWD | 4.72e-19 | 16 | 65 | 9 | SM00216 | |
| Domain | VWF_type-D | 4.72e-19 | 16 | 65 | 9 | IPR001846 | |
| Domain | VWFD | 4.72e-19 | 16 | 65 | 9 | PS51233 | |
| Domain | VWD | 4.72e-19 | 16 | 65 | 9 | PF00094 | |
| Domain | EGF_extracell | NELL2 RELN ADAM19 STAB2 MEGF6 ADAM23 SCARF2 TNC TNN TNR TNXB MEGF10 | 1.33e-18 | 60 | 65 | 12 | IPR013111 |
| Domain | EGF_2 | NELL2 RELN ADAM19 STAB2 MEGF6 ADAM23 SCARF2 TNC TNN TNR TNXB MEGF10 | 1.33e-18 | 60 | 65 | 12 | PF07974 |
| Domain | EGF | SNED1 SLIT2 STAB2 MEGF6 TNC MATN2 NOTCH2NLA LRP4 NID1 TECTA NOTCH2NLC TNXB NOTCH4 CRB1 | 8.80e-18 | 126 | 65 | 14 | PF00008 |
| Domain | VWF_dom | 1.70e-16 | 42 | 65 | 10 | IPR001007 | |
| Domain | Growth_fac_rcpt_ | NELL2 STAB2 MEGF6 SCARF2 TNC TNN MATN2 LRP4 CRELD2 NID1 LAMC2 TNXB NOTCH4 CRB1 | 1.88e-16 | 156 | 65 | 14 | IPR009030 |
| Domain | EGF_CA | SNED1 SLIT2 NELL2 STAB2 MEGF6 MATN2 NOTCH2NLA LRP4 CRELD2 NID1 NOTCH2NLC NOTCH4 CRB1 | 2.53e-16 | 122 | 65 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | SNED1 SLIT2 NELL2 STAB2 MEGF6 MATN2 NOTCH2NLA LRP4 CRELD2 NID1 NOTCH2NLC NOTCH4 CRB1 | 3.14e-16 | 124 | 65 | 13 | IPR001881 |
| Domain | ASX_HYDROXYL | SNED1 SLIT2 NELL2 MEGF6 MATN2 NOTCH2NLA LRP4 CRELD2 NID1 NOTCH2NLC NOTCH4 CRB1 | 8.96e-16 | 100 | 65 | 12 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | SNED1 SLIT2 NELL2 MEGF6 MATN2 NOTCH2NLA LRP4 CRELD2 NID1 NOTCH2NLC NOTCH4 CRB1 | 1.85e-15 | 106 | 65 | 12 | IPR000152 |
| Domain | Cys_knot_C | 1.42e-14 | 25 | 65 | 8 | IPR006207 | |
| Domain | CTCK_2 | 1.42e-14 | 25 | 65 | 8 | PS01225 | |
| Domain | EGF_Ca-bd_CS | SNED1 SLIT2 NELL2 MEGF6 NOTCH2NLA LRP4 CRELD2 NID1 NOTCH2NLC NOTCH4 CRB1 | 2.94e-14 | 97 | 65 | 11 | IPR018097 |
| Domain | EGF_CA | SNED1 SLIT2 NELL2 MEGF6 NOTCH2NLA LRP4 CRELD2 NID1 NOTCH2NLC NOTCH4 CRB1 | 3.71e-14 | 99 | 65 | 11 | PS01187 |
| Domain | VWC | 6.20e-13 | 38 | 65 | 8 | SM00214 | |
| Domain | CT | 7.25e-13 | 22 | 65 | 7 | SM00041 | |
| Domain | EGF_CA | NELL2 MEGF6 MATN2 NOTCH2NLA LRP4 CRELD2 NID1 NOTCH2NLC NOTCH4 | 1.57e-11 | 86 | 65 | 9 | PF07645 |
| Domain | CTCK_1 | 2.52e-11 | 18 | 65 | 6 | PS01185 | |
| Domain | VWFC_2 | 5.14e-11 | 38 | 65 | 7 | PS50184 | |
| Domain | Laminin_EGF | 5.14e-11 | 38 | 65 | 7 | IPR002049 | |
| Domain | hEGF | 4.98e-10 | 28 | 65 | 6 | PF12661 | |
| Domain | EGF_Lam | 2.10e-09 | 35 | 65 | 6 | SM00180 | |
| Domain | VWFC_1 | 2.52e-09 | 36 | 65 | 6 | PS01208 | |
| Domain | Laminin_EGF | 1.31e-07 | 35 | 65 | 5 | PF00053 | |
| Domain | EMI | 3.07e-07 | 17 | 65 | 4 | PS51041 | |
| Domain | NIDO_dom | 4.00e-07 | 5 | 65 | 3 | IPR003886 | |
| Domain | NIDO | 4.00e-07 | 5 | 65 | 3 | SM00539 | |
| Domain | NIDO | 4.00e-07 | 5 | 65 | 3 | PF06119 | |
| Domain | NIDO | 4.00e-07 | 5 | 65 | 3 | PS51220 | |
| Domain | WxxW_domain | 7.99e-07 | 6 | 65 | 3 | IPR025155 | |
| Domain | Mucin2_WxxW | 7.99e-07 | 6 | 65 | 3 | PF13330 | |
| Domain | Fibrinogen_a/b/g_C_2 | 1.35e-06 | 24 | 65 | 4 | IPR014715 | |
| Domain | - | 1.35e-06 | 24 | 65 | 4 | 4.10.530.10 | |
| Domain | Fibrinogen_C | 2.21e-06 | 27 | 65 | 4 | PF00147 | |
| Domain | VWC | 2.57e-06 | 28 | 65 | 4 | PF00093 | |
| Domain | FBG | 2.97e-06 | 29 | 65 | 4 | SM00186 | |
| Domain | - | 3.42e-06 | 30 | 65 | 4 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 3.42e-06 | 30 | 65 | 4 | IPR014716 | |
| Domain | FIBRINOGEN_C_1 | 4.46e-06 | 32 | 65 | 4 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 4.46e-06 | 32 | 65 | 4 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 4.46e-06 | 32 | 65 | 4 | PS51406 | |
| Domain | Fol_N | 6.51e-06 | 11 | 65 | 3 | IPR003645 | |
| Domain | FOLN | 6.51e-06 | 11 | 65 | 3 | SM00274 | |
| Domain | - | 1.95e-05 | 46 | 65 | 4 | 4.10.400.10 | |
| Domain | EMI_domain | 2.18e-05 | 16 | 65 | 3 | IPR011489 | |
| Domain | LDrepeatLR_classA_rpt | 2.52e-05 | 49 | 65 | 4 | IPR002172 | |
| Domain | LDLa | 2.52e-05 | 49 | 65 | 4 | SM00192 | |
| Domain | TILa | 3.57e-05 | 3 | 65 | 2 | PF12714 | |
| Domain | TILa_dom | 3.57e-05 | 3 | 65 | 2 | IPR025615 | |
| Domain | - | 4.40e-05 | 20 | 65 | 3 | 4.10.70.10 | |
| Domain | Disintegrin | 5.12e-05 | 21 | 65 | 3 | PF00200 | |
| Domain | DISIN | 5.12e-05 | 21 | 65 | 3 | SM00050 | |
| Domain | cEGF | 9.88e-05 | 26 | 65 | 3 | IPR026823 | |
| Domain | cEGF | 9.88e-05 | 26 | 65 | 3 | PF12662 | |
| Domain | MetalloPept_cat_dom | 1.82e-04 | 81 | 65 | 4 | IPR024079 | |
| Domain | - | 1.82e-04 | 81 | 65 | 4 | 3.40.390.10 | |
| Domain | Notch_dom | 2.48e-04 | 7 | 65 | 2 | IPR000800 | |
| Domain | Notch | 2.48e-04 | 7 | 65 | 2 | PF00066 | |
| Domain | NL | 2.48e-04 | 7 | 65 | 2 | SM00004 | |
| Domain | fn3 | 2.51e-04 | 162 | 65 | 5 | PF00041 | |
| Domain | - | 3.35e-04 | 95 | 65 | 4 | 2.60.120.200 | |
| Domain | Peptidase_M12B_N | 3.36e-04 | 39 | 65 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 3.36e-04 | 39 | 65 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 3.63e-04 | 40 | 65 | 3 | PS00427 | |
| Domain | LDLR_class-A_CS | 3.63e-04 | 40 | 65 | 3 | IPR023415 | |
| Domain | Reprolysin | 3.63e-04 | 40 | 65 | 3 | PF01421 | |
| Domain | Laminin_G_2 | 3.63e-04 | 40 | 65 | 3 | PF02210 | |
| Domain | ADAM_MEPRO | 3.63e-04 | 40 | 65 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.63e-04 | 40 | 65 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 3.63e-04 | 40 | 65 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 3.90e-04 | 41 | 65 | 3 | IPR001762 | |
| Domain | Plexin_cytopl | 4.23e-04 | 9 | 65 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 4.23e-04 | 9 | 65 | 2 | IPR013548 | |
| Domain | Plexin | 4.23e-04 | 9 | 65 | 2 | IPR031148 | |
| Domain | Sialidases | 4.23e-04 | 9 | 65 | 2 | IPR011040 | |
| Domain | FN3 | 4.61e-04 | 185 | 65 | 5 | SM00060 | |
| Domain | LamG | 4.81e-04 | 44 | 65 | 3 | SM00282 | |
| Domain | Ldl_recept_a | 5.14e-04 | 45 | 65 | 3 | PF00057 | |
| Domain | ZP_dom_CS | 5.27e-04 | 10 | 65 | 2 | IPR017977 | |
| Domain | LDLRA_1 | 6.22e-04 | 48 | 65 | 3 | PS01209 | |
| Domain | FN3 | 6.42e-04 | 199 | 65 | 5 | PS50853 | |
| Domain | - | 6.43e-04 | 11 | 65 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 6.43e-04 | 11 | 65 | 2 | IPR023413 | |
| Domain | LDLRA_2 | 6.61e-04 | 49 | 65 | 3 | PS50068 | |
| Domain | EGF_3 | 7.70e-04 | 12 | 65 | 2 | PF12947 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.98e-09 | 300 | 47 | 11 | M610 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.01e-08 | 258 | 47 | 10 | MM14572 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.07e-08 | 84 | 47 | 7 | M7098 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 6.23e-07 | 21 | 47 | 4 | MM15706 | |
| Pathway | WP_FOCAL_ADHESION | 2.59e-06 | 187 | 47 | 7 | MM15913 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.95e-06 | 68 | 47 | 5 | M27303 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 3.28e-06 | 124 | 47 | 6 | M27285 | |
| Pathway | WP_FOCAL_ADHESION | 3.92e-06 | 199 | 47 | 7 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.92e-06 | 199 | 47 | 7 | M7253 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.12e-06 | 76 | 47 | 5 | M27219 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.74e-05 | 47 | 47 | 4 | MM14925 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.89e-05 | 16 | 47 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.29e-05 | 17 | 47 | 3 | M27412 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.99e-05 | 109 | 47 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.61e-05 | 60 | 47 | 4 | MM15636 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 4.74e-05 | 120 | 47 | 5 | MM14982 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.83e-05 | 302 | 47 | 7 | M39719 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 5.87e-05 | 23 | 47 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 8.56e-05 | 26 | 47 | 3 | M27483 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 9.42e-05 | 326 | 47 | 7 | MM15917 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.09e-04 | 143 | 47 | 5 | M27275 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.20e-04 | 339 | 47 | 7 | M39736 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 3.86e-04 | 9 | 47 | 2 | MM15030 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 4.81e-04 | 10 | 47 | 2 | M27348 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.00e-04 | 111 | 47 | 4 | M27416 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 5.87e-04 | 11 | 47 | 2 | M27882 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 9.65e-04 | 14 | 47 | 2 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 9.65e-04 | 14 | 47 | 2 | M7578 | |
| Pathway | PID_NOTCH_PATHWAY | 9.91e-04 | 59 | 47 | 3 | M17 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.11e-03 | 15 | 47 | 2 | MM14922 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.11e-03 | 15 | 47 | 2 | MM15031 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.14e-03 | 62 | 47 | 3 | M546 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.19e-03 | 140 | 47 | 4 | M587 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.27e-03 | 16 | 47 | 2 | M16498 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.27e-03 | 16 | 47 | 2 | M8245 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.37e-03 | 66 | 47 | 3 | M18 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.41e-03 | 250 | 47 | 5 | M27554 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 2.41e-03 | 22 | 47 | 2 | M39480 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 2.63e-03 | 23 | 47 | 2 | MM15936 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.62e-03 | 27 | 47 | 2 | M39545 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.46e-03 | 30 | 47 | 2 | M27216 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 5.06e-03 | 32 | 47 | 2 | M165 | |
| Pubmed | SLIT2 RELN VWF MEGF6 TNC MATN2 CRELD2 NID1 PLG ADAM10 SSPOP TNXB PLXNA2 | 1.37e-17 | 175 | 66 | 13 | 28071719 | |
| Pubmed | 8.31e-13 | 167 | 66 | 10 | 22159717 | ||
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 17471237 | ||
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 1.18e-11 | 4 | 66 | 4 | 29869461 | |
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 23807779 | ||
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 12676567 | ||
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 19110483 | ||
| Pubmed | 5.40e-10 | 153 | 66 | 8 | 25037231 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 7530141 | ||
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 6.53e-09 | 3 | 66 | 3 | 7694605 | |
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 18825309 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 18300795 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 19718741 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 7.30e-09 | 135 | 66 | 7 | 28675934 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 33154304 | ||
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 2.61e-08 | 4 | 66 | 3 | 24901817 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 25638393 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 36367122 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 2.61e-08 | 4 | 66 | 3 | 22269464 | |
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 2.61e-08 | 4 | 66 | 3 | 20929551 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 21596555 | ||
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 2.61e-08 | 4 | 66 | 3 | 27298226 | |
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 2.61e-08 | 4 | 66 | 3 | 17401217 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 25298197 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 3.55e-08 | 18 | 66 | 4 | 18834073 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 6.51e-08 | 5 | 66 | 3 | 11062147 | |
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 24840470 | ||
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 22261707 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 6.51e-08 | 5 | 66 | 3 | 16188033 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 6.51e-08 | 5 | 66 | 3 | 16475027 | |
| Pubmed | 1.30e-07 | 6 | 66 | 3 | 17982272 | ||
| Pubmed | Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus. | 1.45e-07 | 25 | 66 | 4 | 34391772 | |
| Pubmed | 1.47e-07 | 64 | 66 | 5 | 22261194 | ||
| Pubmed | 2.27e-07 | 7 | 66 | 3 | 15162516 | ||
| Pubmed | 2.27e-07 | 7 | 66 | 3 | 32581832 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.69e-07 | 248 | 66 | 7 | 24006456 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.12e-06 | 560 | 66 | 9 | 21653829 | |
| Pubmed | 1.14e-06 | 41 | 66 | 4 | 22675208 | ||
| Pubmed | 1.42e-06 | 12 | 66 | 3 | 10101119 | ||
| Pubmed | 3.03e-06 | 210 | 66 | 6 | 16537572 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 7513696 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 17203232 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 28279966 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 34058148 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 3.55e-06 | 2 | 66 | 2 | 14988081 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 15563276 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 9321695 | ||
| Pubmed | Interaction of human pregnancy-associated plasma protein-A with serine proteinases. | 3.55e-06 | 2 | 66 | 2 | 7586586 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 17621824 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 24317696 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 22391959 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 14718370 | ||
| Pubmed | Tenascins and inflammation in disorders of the nervous system. | 3.55e-06 | 2 | 66 | 2 | 23269478 | |
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 3.55e-06 | 2 | 66 | 2 | 35776514 | |
| Pubmed | Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. | 3.55e-06 | 2 | 66 | 2 | 12527922 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 24327612 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 19432394 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 3.55e-06 | 2 | 66 | 2 | 21653907 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 28321513 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 9407109 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 9422745 | ||
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 3.55e-06 | 2 | 66 | 2 | 36427316 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 8856503 | ||
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 3.55e-06 | 2 | 66 | 2 | 28607090 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 30504806 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 12360467 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 17321686 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 3.55e-06 | 2 | 66 | 2 | 23272068 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 31030254 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 3.55e-06 | 2 | 66 | 2 | 27729120 | |
| Pubmed | Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. | 3.55e-06 | 2 | 66 | 2 | 20731025 | |
| Pubmed | Association study between the TNXB locus and schizophrenia in a Japanese population. | 3.55e-06 | 2 | 66 | 2 | 17192952 | |
| Pubmed | Extracellular matrix changes in corneal opacification vary depending on etiology. | 3.55e-06 | 2 | 66 | 2 | 33633437 | |
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 3.55e-06 | 2 | 66 | 2 | 23527003 | |
| Pubmed | The complete genomic organization of the human MUC6 and MUC2 mucin genes. | 3.55e-06 | 2 | 66 | 2 | 15081123 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16540890 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 36111525 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 34126068 | ||
| Pubmed | High-fat Diet Alters the Glycosylation Patterns of Duodenal Mucins in a Murine Model. | 3.55e-06 | 2 | 66 | 2 | 32141795 | |
| Pubmed | MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis. | 3.55e-06 | 2 | 66 | 2 | 20878553 | |
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 3.55e-06 | 2 | 66 | 2 | 27845589 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 11445551 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16262655 | ||
| Pubmed | Tenascins are associated with lipid rafts isolated from mouse brain. | 3.55e-06 | 2 | 66 | 2 | 12056833 | |
| Pubmed | Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. | 3.55e-06 | 2 | 66 | 2 | 12359049 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 27435107 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 17202312 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 22211116 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 35681468 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 26871672 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 23832517 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 23832516 | ||
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 3.55e-06 | 2 | 66 | 2 | 20873538 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 11988092 | ||
| Pubmed | The change in tenascin expression in mouse uterus during early pregnancy. | 3.55e-06 | 2 | 66 | 2 | 9013311 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 24101721 | ||
| Pubmed | Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer. | 3.55e-06 | 2 | 66 | 2 | 29999571 | |
| Pubmed | Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma. | 3.55e-06 | 2 | 66 | 2 | 14594655 | |
| Interaction | FBXO2 interactions | 5.00e-06 | 411 | 63 | 9 | int:FBXO2 | |
| Interaction | GNG8 interactions | 4.46e-05 | 125 | 63 | 5 | int:GNG8 | |
| Interaction | NCAN interactions | 5.62e-05 | 24 | 63 | 3 | int:NCAN | |
| Cytoband | 11p15.5 | 2.64e-05 | 118 | 66 | 4 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.33e-03 | 564 | 66 | 5 | chr11p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 1.83e-03 | 167 | 66 | 3 | chr1q25 | |
| Cytoband | 1q43 | 2.48e-03 | 51 | 66 | 2 | 1q43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 3.00e-03 | 681 | 66 | 5 | chr1p36 | |
| Cytoband | 1p36.21 | 3.76e-03 | 63 | 66 | 2 | 1p36.21 | |
| Cytoband | 1p36.33 | 5.56e-03 | 77 | 66 | 2 | 1p36.33 | |
| GeneFamily | CD molecules|Mucins | 8.66e-08 | 21 | 37 | 4 | 648 | |
| GeneFamily | Fibrinogen C domain containing | 1.82e-07 | 25 | 37 | 4 | 554 | |
| GeneFamily | Fibronectin type III domain containing | 1.77e-05 | 160 | 37 | 5 | 555 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.23e-05 | 27 | 37 | 3 | 47 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.23e-05 | 27 | 37 | 3 | 1253 | |
| GeneFamily | Plexins | 1.45e-04 | 9 | 37 | 2 | 683 | |
| GeneFamily | PRAME family | 1.09e-03 | 24 | 37 | 2 | 686 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.06e-03 | 57 | 37 | 2 | 1179 | |
| Coexpression | NABA_MATRISOME | PLXNA3 SNED1 SLIT2 NELL2 RELN TINAG ADAM19 VWF IGFALS MEGF6 ADAM23 TNC TNN MATN2 CRELD2 NID1 PAPPA LAMC2 MUC5B PLG TECTA ADAM10 MUC2 TNR SSPOP MUC5AC TNXB MUC6 PLXNA2 MEGF10 EGFEM1P OTOG | 3.48e-28 | 1008 | 65 | 32 | MM17056 |
| Coexpression | NABA_MATRISOME | PLXNA3 SNED1 SLIT2 NELL2 RELN TINAG ADAM19 VWF IGFALS MEGF6 ADAM23 TNC TNN MATN2 CRELD2 NID1 PAPPA LAMC2 MUC5B PLG TECTA ZP4 ADAM10 MUC2 TNR SSPOP MUC5AC TNXB MUC6 PLXNA2 MEGF10 OTOG | 6.04e-28 | 1026 | 65 | 32 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SNED1 SLIT2 NELL2 RELN TINAG VWF IGFALS TNC TNN MATN2 CRELD2 NID1 LAMC2 TECTA TNR SSPOP TNXB EGFEM1P OTOG | 9.01e-26 | 191 | 65 | 19 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SNED1 SLIT2 NELL2 RELN TINAG VWF IGFALS TNC TNN MATN2 CRELD2 NID1 LAMC2 TECTA ZP4 TNR SSPOP TNXB OTOG | 1.50e-25 | 196 | 65 | 19 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | SNED1 SLIT2 NELL2 RELN TINAG VWF IGFALS TNC TNN MATN2 CRELD2 NID1 LAMC2 TECTA TNR SSPOP TNXB EGFEM1P OTOG | 7.48e-23 | 270 | 65 | 19 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | SNED1 SLIT2 NELL2 RELN TINAG VWF IGFALS TNC TNN MATN2 CRELD2 NID1 LAMC2 TECTA ZP4 TNR SSPOP TNXB OTOG | 1.06e-22 | 275 | 65 | 19 | M5884 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PLXNA3 ADAM19 MEGF6 ADAM23 PAPPA MUC5B PLG ADAM10 MUC2 MUC5AC MUC6 PLXNA2 MEGF10 | 2.68e-08 | 738 | 65 | 13 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PLXNA3 ADAM19 MEGF6 ADAM23 PAPPA MUC5B PLG ADAM10 MUC2 MUC5AC MUC6 PLXNA2 MEGF10 | 3.29e-08 | 751 | 65 | 13 | M5885 |
| Coexpression | NABA_ECM_AFFILIATED | 2.69e-06 | 158 | 65 | 6 | MM17063 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.10e-06 | 170 | 65 | 6 | M5880 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LIVER_METASTASIS | 5.20e-06 | 14 | 65 | 3 | M48002 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 1.61e-05 | 20 | 65 | 3 | MM17053 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.49e-05 | 23 | 65 | 3 | M48001 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 3.46e-05 | 505 | 65 | 8 | M39167 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 5.77e-05 | 543 | 65 | 8 | MM997 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | ADAM19 STAB2 TRAFD1 IGFALS MEGF6 ZFR2 TECTA TNXB PLXNA2 CRB1 | 7.61e-05 | 909 | 65 | 10 | M41018 |
| Coexpression | SRC_UP.V1_UP | 8.11e-05 | 178 | 65 | 5 | M2714 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | 8.55e-05 | 180 | 65 | 5 | MM612 | |
| Coexpression | LIU_CDX2_TARGETS_UP | 9.00e-05 | 35 | 65 | 3 | M16637 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PLXNA3 SNED1 RELN PRAMEF5 TMC7 MATN2 LRP4 PRAG1 TNR GDI1 PRAMEF6 | 9.16e-05 | 1124 | 65 | 11 | MM1070 |
| Coexpression | DURAND_STROMA_S_UP | 1.00e-04 | 300 | 65 | 6 | M2581 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 1.04e-04 | 98 | 65 | 4 | MM592 | |
| Coexpression | DURAND_STROMA_S_UP | 1.08e-04 | 304 | 65 | 6 | MM1083 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | 1.31e-04 | 104 | 65 | 4 | M45682 | |
| Coexpression | GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN | 1.37e-04 | 199 | 65 | 5 | M8070 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN | 1.40e-04 | 200 | 65 | 5 | M3450 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 1.45e-04 | 41 | 65 | 3 | M47988 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.82e-04 | 479 | 65 | 7 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.91e-04 | 483 | 65 | 7 | MM1082 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.23e-04 | 221 | 65 | 5 | M39222 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 2.42e-04 | 225 | 65 | 5 | M6175 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 2.85e-04 | 233 | 65 | 5 | M13273 | |
| Coexpression | NABA_ECM_REGULATORS | 3.14e-04 | 238 | 65 | 5 | M3468 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 3.20e-04 | 239 | 65 | 5 | MM1274 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN | 3.30e-04 | 54 | 65 | 3 | M5312 | |
| Coexpression | NABA_ECM_REGULATORS | 3.39e-04 | 242 | 65 | 5 | MM17062 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN | 3.87e-04 | 57 | 65 | 3 | MM463 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 3.99e-04 | 721 | 65 | 8 | M1999 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 4.07e-04 | 58 | 65 | 3 | M178 | |
| Coexpression | LUCAS_HNF4A_TARGETS_UP | 4.07e-04 | 58 | 65 | 3 | M11410 | |
| Coexpression | KRAS.LUNG.BREAST_UP.V1_UP | 4.21e-04 | 141 | 65 | 4 | M2900 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 4.96e-04 | 404 | 65 | 6 | M19488 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 3.59e-06 | 320 | 61 | 8 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 1.17e-05 | 498 | 61 | 9 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | PLXNA3 RELN ADAM19 VWF MEGF6 SCARF2 TNC TNFRSF19 PRAG1 GDI1 PLXNA2 RAI1 SORCS1 | 1.91e-05 | 1153 | 61 | 13 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | 3.33e-05 | 213 | 61 | 6 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.33e-05 | 213 | 61 | 6 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 3.53e-05 | 439 | 61 | 8 | GSM777059_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 7.50e-05 | 78 | 61 | 4 | ratio_EB_vs_SC_500_K2 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 1.28e-04 | 170 | 61 | 5 | ratio_DE_vs_SC_500_K2 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.51e-04 | 280 | 61 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_100 | 1.89e-04 | 99 | 61 | 4 | PCBC_ratio_DE_vs_SC_100 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.20e-04 | 428 | 61 | 7 | JC_hmvEC_1000_K4 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 2.33e-04 | 734 | 61 | 9 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.55e-04 | 197 | 61 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.00e-04 | 204 | 61 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.06e-04 | 205 | 61 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.81e-04 | 215 | 61 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 3.99e-04 | 967 | 61 | 10 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.01e-04 | 336 | 61 | 6 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | 4.02e-04 | 968 | 61 | 10 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 4.47e-04 | 124 | 61 | 4 | ratio_ECTO_vs_SC_500_K2 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 4.65e-04 | 986 | 61 | 10 | PCBC_EB_fibroblast_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | 4.73e-04 | 486 | 61 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | 4.95e-04 | 994 | 61 | 10 | PCBC_EB_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | 4.95e-04 | 994 | 61 | 10 | PCBC_ratio_EB_vs_SC_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#2_top-relative-expression-ranked_500 | 5.19e-04 | 129 | 61 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k2 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500 | 5.27e-04 | 495 | 61 | 7 | PCBC_ratio_DE_vs_SC_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_500 | 5.27e-04 | 495 | 61 | 7 | PCBC_ratio_MESO-5_vs_SC_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.65e-04 | 243 | 61 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 6.77e-04 | 244 | 61 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 7.42e-04 | 249 | 61 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 7.64e-04 | 143 | 61 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.97e-04 | 383 | 61 | 6 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-10 | 182 | 66 | 8 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-10 | 188 | 66 | 8 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-10 | 188 | 66 | 8 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-10 | 188 | 66 | 8 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.29e-09 | 177 | 66 | 7 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.31e-09 | 180 | 66 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-08 | 183 | 66 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-08 | 185 | 66 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.17e-08 | 186 | 66 | 7 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.26e-08 | 188 | 66 | 7 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.40e-08 | 191 | 66 | 7 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-08 | 193 | 66 | 7 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.93e-08 | 200 | 66 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.63e-07 | 178 | 66 | 6 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.63e-07 | 178 | 66 | 6 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-07 | 183 | 66 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-07 | 183 | 66 | 6 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 66 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 66 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 66 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-07 | 185 | 66 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.30e-07 | 185 | 66 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 3.30e-07 | 185 | 66 | 6 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-07 | 186 | 66 | 6 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-07 | 186 | 66 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.74e-07 | 189 | 66 | 6 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.74e-07 | 189 | 66 | 6 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 3.86e-07 | 190 | 66 | 6 | bce09634acbc2cfd53666328e8aed8bf8835f845 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 3.86e-07 | 190 | 66 | 6 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | 21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 3.86e-07 | 190 | 66 | 6 | 08437396a98ca9526f69c3a74bbf2929f3c68b8e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.98e-07 | 191 | 66 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 192 | 66 | 6 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 4.10e-07 | 192 | 66 | 6 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 192 | 66 | 6 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.10e-07 | 192 | 66 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 192 | 66 | 6 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.23e-07 | 193 | 66 | 6 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.36e-07 | 194 | 66 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-07 | 195 | 66 | 6 | b0d408f8bc1701a87596ed55efcd90749fee33e6 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-07 | 195 | 66 | 6 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-07 | 195 | 66 | 6 | a486a7acea0e91048cc48afa0dbd3926d30bc217 | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.63e-07 | 196 | 66 | 6 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.77e-07 | 197 | 66 | 6 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-07 | 197 | 66 | 6 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.77e-07 | 197 | 66 | 6 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.06e-07 | 199 | 66 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.06e-07 | 199 | 66 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.06e-07 | 199 | 66 | 6 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.06e-07 | 199 | 66 | 6 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.21e-07 | 200 | 66 | 6 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.21e-07 | 200 | 66 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 5.21e-07 | 200 | 66 | 6 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.43e-06 | 155 | 66 | 5 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-06 | 163 | 66 | 5 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | Endothelial-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.66e-06 | 165 | 66 | 5 | b6893882472aeb0d18e26f47eaec9d53688afcde | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-06 | 166 | 66 | 5 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.80e-06 | 166 | 66 | 5 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-06 | 166 | 66 | 5 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-06 | 166 | 66 | 5 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-06 | 166 | 66 | 5 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.08e-06 | 168 | 66 | 5 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-06 | 168 | 66 | 5 | 948d9e9972bd2a4b503d55fa69b70dd568a35a67 | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.23e-06 | 169 | 66 | 5 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-06 | 172 | 66 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.70e-06 | 172 | 66 | 5 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 5.86e-06 | 173 | 66 | 5 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 174 | 66 | 5 | 76310c0af1d7df6a4de3816838b2ac2892f68746 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.03e-06 | 174 | 66 | 5 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 6.03e-06 | 174 | 66 | 5 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.03e-06 | 174 | 66 | 5 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 175 | 66 | 5 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 175 | 66 | 5 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 175 | 66 | 5 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.37e-06 | 176 | 66 | 5 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.55e-06 | 177 | 66 | 5 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 6.73e-06 | 178 | 66 | 5 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | wk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.92e-06 | 179 | 66 | 5 | ab23fee9adab1e63d5b5cd9faba6b9a92beef425 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 6.92e-06 | 179 | 66 | 5 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-06 | 180 | 66 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-06 | 180 | 66 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 181 | 66 | 5 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.50e-06 | 182 | 66 | 5 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | Club-club-8|World / Class top | 7.50e-06 | 182 | 66 | 5 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-06 | 182 | 66 | 5 | e3248d108b51c49ca2c978636e13017e23b53860 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.50e-06 | 182 | 66 | 5 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.50e-06 | 182 | 66 | 5 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.50e-06 | 182 | 66 | 5 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-06 | 182 | 66 | 5 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.50e-06 | 182 | 66 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | wk_15-18-Epithelial-PNS-Late_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.50e-06 | 182 | 66 | 5 | 6462e0469224457e249d10e224082f727caa02d6 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.70e-06 | 183 | 66 | 5 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 7.70e-06 | 183 | 66 | 5 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | wk_15-18-Epithelial-PNS-intermediate_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.70e-06 | 183 | 66 | 5 | d874aa9a856f79626c8a8371f6196a77b7d662ee | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.70e-06 | 183 | 66 | 5 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.70e-06 | 183 | 66 | 5 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.70e-06 | 183 | 66 | 5 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-06 | 183 | 66 | 5 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.70e-06 | 183 | 66 | 5 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-06 | 184 | 66 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 184 | 66 | 5 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| Computational | Adhesion molecules. | 6.45e-06 | 141 | 36 | 6 | MODULE_122 | |
| Drug | Gdrgdsp | 2.35e-08 | 109 | 64 | 7 | CID000115346 | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 7.66e-08 | 196 | 64 | 8 | 5593_UP | |
| Drug | 3-ethylpyridine | 8.46e-08 | 4 | 64 | 3 | CID000010823 | |
| Drug | Rgd Peptide | 3.50e-07 | 239 | 64 | 8 | CID000104802 | |
| Drug | AC1O5SNJ | 4.21e-07 | 6 | 64 | 3 | CID006439900 | |
| Drug | cyclofenil | 1.69e-06 | 31 | 64 | 4 | CID000002898 | |
| Drug | TN-2 | 7.76e-06 | 45 | 64 | 4 | CID006852143 | |
| Drug | 4-toluenesulfonyl fluoride | 7.78e-06 | 2 | 64 | 2 | ctd:C003614 | |
| Drug | geldanamycin; Up 200; 1uM; HL60; HT_HG-U133A | 1.23e-05 | 182 | 64 | 6 | 2688_UP | |
| Drug | Gleevec; Up 200; 10uM; PC3; HG-U133A | 1.87e-05 | 196 | 64 | 6 | 483_UP | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 2862_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 2329_UP | |
| Drug | AC1MHG1S | 2.33e-05 | 3 | 64 | 2 | CID003025825 | |
| Drug | NSC3077 | 2.33e-05 | 20 | 64 | 3 | CID000025889 | |
| Drug | 2,3-pentanedione | 3.15e-05 | 129 | 64 | 5 | ctd:C013186 | |
| Drug | Cytarabine | 4.26e-05 | 598 | 64 | 9 | ctd:D003561 | |
| Drug | CGP 15720A | 4.65e-05 | 4 | 64 | 2 | CID003035698 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 9.25e-08 | 5 | 63 | 3 | DOID:3030 (is_marker_for) | |
| Disease | cystitis (is_marker_for) | 4.49e-06 | 2 | 63 | 2 | DOID:1679 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.09e-05 | 64 | 63 | 4 | DOID:4947 (is_marker_for) | |
| Disease | sputum mucin-5B amount | 1.34e-05 | 3 | 63 | 2 | OBA_2050332 | |
| Disease | osteonecrosis (is_marker_for) | 2.68e-05 | 4 | 63 | 2 | DOID:10159 (is_marker_for) | |
| Disease | factor VIII measurement, venous thromboembolism | 5.29e-05 | 34 | 63 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | Noonan syndrome (is_marker_for) | 6.69e-05 | 6 | 63 | 2 | DOID:3490 (is_marker_for) | |
| Disease | asthma (is_marker_for) | 1.55e-04 | 126 | 63 | 4 | DOID:2841 (is_marker_for) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 1.60e-04 | 9 | 63 | 2 | EFO_0009824 | |
| Disease | tenascin measurement | 2.00e-04 | 10 | 63 | 2 | EFO_0008296 | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 2.00e-04 | 10 | 63 | 2 | EFO_0022035 | |
| Disease | pulmonary fibrosis | 2.44e-04 | 11 | 63 | 2 | EFO_0009448 | |
| Disease | pyroglutamine measurement | 2.63e-04 | 58 | 63 | 3 | EFO_0005408 | |
| Disease | cystic fibrosis (is_marker_for) | 3.21e-04 | 62 | 63 | 3 | DOID:1485 (is_marker_for) | |
| Disease | gastric ulcer (implicated_via_orthology) | 4.02e-04 | 14 | 63 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | venous thromboembolism, fibrinogen measurement | 4.03e-04 | 67 | 63 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | interstitial lung disease | 4.03e-04 | 67 | 63 | 3 | EFO_0004244 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 4.63e-04 | 15 | 63 | 2 | EFO_0010367 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 5.28e-04 | 16 | 63 | 2 | EFO_0020346 | |
| Disease | Schizophrenia | 5.63e-04 | 883 | 63 | 8 | C0036341 | |
| Disease | Nonsyndromic Deafness | 7.03e-04 | 81 | 63 | 3 | C3711374 | |
| Disease | X-11470 measurement | 7.49e-04 | 19 | 63 | 2 | EFO_0021241 | |
| Disease | carotid artery disease (is_marker_for) | 7.49e-04 | 19 | 63 | 2 | DOID:3407 (is_marker_for) | |
| Disease | factor VIII measurement, Ischemic stroke | 7.49e-04 | 19 | 63 | 2 | EFO_0004630, HP_0002140 | |
| Disease | bipolar disorder (is_marker_for) | 7.49e-04 | 19 | 63 | 2 | DOID:3312 (is_marker_for) | |
| Disease | asthma | 1.08e-03 | 751 | 63 | 7 | MONDO_0004979 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 1.10e-03 | 23 | 63 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | FEV/FEC ratio | 1.14e-03 | 1228 | 63 | 9 | EFO_0004713 | |
| Disease | diffusing capacity of the lung for carbon monoxide | 1.15e-03 | 96 | 63 | 3 | EFO_0009369 | |
| Disease | Inhalant adrenergic use measurement | 1.15e-03 | 96 | 63 | 3 | EFO_0009941 | |
| Disease | Liver Cirrhosis, Experimental | 1.29e-03 | 774 | 63 | 7 | C0023893 | |
| Disease | complement C4b measurement | 1.30e-03 | 25 | 63 | 2 | EFO_0008092 | |
| Disease | myeloperoxidase measurement | 1.41e-03 | 26 | 63 | 2 | EFO_0005243 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 1.52e-03 | 27 | 63 | 2 | EFO_0004629, EFO_0004630 | |
| Disease | Oral ulcer | 1.57e-03 | 107 | 63 | 3 | HP_0000155 | |
| Disease | susceptibility to rheumatic fever measurement | 1.64e-03 | 28 | 63 | 2 | EFO_0008416 | |
| Disease | arteriosclerosis (is_marker_for) | 1.76e-03 | 29 | 63 | 2 | DOID:2349 (is_marker_for) | |
| Disease | colorectal cancer, overall survival | 1.76e-03 | 29 | 63 | 2 | EFO_0000638, MONDO_0005575 | |
| Disease | factor XI measurement, venous thromboembolism | 1.88e-03 | 30 | 63 | 2 | EFO_0004286, EFO_0004694 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 1.88e-03 | 30 | 63 | 2 | EFO_0004629, HP_0002140 | |
| Disease | stroke outcome severity measurement | 1.88e-03 | 114 | 63 | 3 | EFO_0009603 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.08e-03 | 118 | 63 | 3 | EFO_0001645, EFO_0004629 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DCRDCSDEAQCGYHG | 41 | Q6UXC1 | |
| ECDITEYCTGDSGQC | 566 | O75077 | |
| EQGEECDCGYSDQCK | 466 | O14672 | |
| DSADCCSASAADGGC | 356 | Q9H013 | |
| CPAACVCSYDDDADE | 41 | P35858 | |
| YEACVNDACACDSGG | 1106 | Q9HC84 | |
| CDSGGDCECFCTAVA | 1116 | Q9HC84 | |
| QSCYCCDGREDGGEE | 1781 | Q7Z5J4 | |
| CRCASGFTGEDCQYS | 51 | Q7Z3S9 | |
| DGTYGLNCAERCDCS | 531 | Q96KG7 | |
| GDCECLCDAVAAYAQ | 1096 | Q6W4X9 | |
| SYVSDGCADGEESDC | 1306 | Q8IY17 | |
| CDILESACCDHSGSY | 91 | Q9H8M7 | |
| GCEHICVNSDDSYTC | 576 | O00339 | |
| CVNSDDSYTCECLEG | 581 | O00339 | |
| DTICFNLDGGYDCRC | 616 | Q99435 | |
| VCDCCDGTDEYNSGV | 96 | P14314 | |
| PDAAAYCCSACHGDE | 16 | O95544 | |
| CEQYTTCGECLSSGD | 511 | O75051 | |
| CEQYQSCAACLGSGD | 491 | P51805 | |
| SCDTGGDCECFCSAV | 1081 | Q02817 | |
| FGQDCAETCDCAPDA | 311 | Q5VY43 | |
| CECVEGYQFSDEGTC | 736 | P14543 | |
| YEACVNDACACDSGG | 1116 | P98088 | |
| CDSGGDCECFCTAVA | 1126 | P98088 | |
| HYDCAELESCLDGCI | 321 | Q96KJ4 | |
| CNYERFNFDGGECCD | 461 | Q13219 | |
| CRCASGFTGEDCQYS | 51 | P0DPK4 | |
| DCISGVCFCDLGYTA | 1421 | P78509 | |
| DNCDDGLCTNGCKYE | 196 | P54108 | |
| GCAEGCQCDSGFLYN | 1561 | Q9Y6R7 | |
| DGCAEGCQCDSGFLY | 2761 | Q9Y6R7 | |
| CYSGDENPDIECADC | 431 | Q13753 | |
| DDGCESQVFCSCSYD | 391 | P31150 | |
| GATCQDALGAYFCDC | 236 | P82279 | |
| NGSYTCEECDSSCVG | 251 | Q6UXH1 | |
| CLEGAYGAGCTSECQ | 56 | Q0D2K5 | |
| YGAGCTSECQCVEEN | 61 | Q0D2K5 | |
| QGGDCECFCASVSAY | 1206 | Q6ZRI0 | |
| SCDAISGLCLCEAGY | 881 | O75095 | |
| LYDACGCDSGGDCEC | 1231 | A2VEC9 | |
| GDCECLCSAIATYAD | 1241 | A2VEC9 | |
| EDYCGARTELCGNCG | 106 | O14545 | |
| CEEECMHCSGENYDG | 181 | P00747 | |
| PQCDSEECLFDGYDC | 1231 | Q99466 | |
| ACAFYECSACTGEGN | 141 | Q96A58 | |
| CDAHDDSYTCECPRG | 556 | Q8TER0 | |
| DCDLQEDACYNCGRG | 66 | P62633 | |
| DSCSEGCQCDEGYAL | 1011 | O75443 | |
| DCCPDCGNRSFYDLE | 456 | Q5VXH4 | |
| ECCGRDLYVGTNDCF | 31 | Q8WUH2 | |
| SCCYDCVDCEAGSYR | 516 | Q7RTX0 | |
| CDLCAVSCTGADAYA | 321 | Q9UPR6 | |
| YDTCSCESIGDCACF | 1086 | P04275 | |
| GFCDTGECYCEEGFT | 241 | Q9UQP3 | |
| GECYCEEGFTGLDCA | 246 | Q9UQP3 | |
| GTYGEDCAFVCADCG | 366 | Q96GP6 | |
| GRCEDGECICDTGYS | 381 | P22105 | |
| GECICDTGYSGDDCG | 386 | P22105 | |
| GLCEDGVCVCDAGYS | 536 | P22105 | |
| GVCVCDAGYSGEDCS | 541 | P22105 | |
| CEDGYSGEDCGVRQC | 576 | P22105 | |
| DGSCVCKDGYAGEDC | 731 | P22105 | |
| DCCPDCGNRSFYDLE | 456 | Q5TYX0 | |
| CICFEGYAGADCSRE | 236 | P24821 | |
| GQCVCDEGYTGEDCS | 421 | P24821 | |
| SGRCICNEGYSGEDC | 606 | P24821 | |
| DGQCICDSEYSGDDC | 216 | Q92752 | |
| CDSEYSGDDCSELRC | 221 | Q92752 | |
| TEACCAEGADPDCYD | 71 | P02774 | |
| CNSGLDGDGTCECYS | 171 | Q8WWQ8 | |
| TCECNLDYEGDGITC | 2066 | Q8WWQ8 | |
| CECSSGYTGDSCDRE | 1436 | O94813 | |
| CEFCGCDFSGEAYES | 141 | Q9BUZ4 | |
| GDSEGGEYCSILDCC | 246 | Q86YV5 | |
| ECGFGYGEDAQCVTC | 61 | Q9NS68 | |
| YCRNFGCCEDRDDGC | 56 | Q9UJW2 | |
| GCCEDRDDGCVTEFY | 61 | Q9UJW2 | |
| CVCTEADFDCDYGYE | 721 | Q8WY21 | |
| YECSECGKAFCESAA | 371 | Q5CZA5 | |
| RGDCEGLGCCYSSEE | 161 | Q12836 | |
| ITSCDDDTCDLCGYN | 466 | Q7Z402 | |
| VNECAEEGYCSQGCT | 396 | O75096 |